Besifloxacin Potent Against Multidrug-Resistant Organisms

Besifloxacin (Besivance, Bausch + Lomb) demonstrated potent activity and high rates of eradication against problematic multidrug-resistant organisms that cause ocular infections, according to the results of two studies presented at ARVO. Findings from 2011’s Antibiotic Resistance Monitoring in Ocular Microorganism...

Full Story →